Strategic Technologies for Europe Platform (STEP)

European Parliament Publishes Study On Chinese Industrial Overcapacity In Key Green-Tech Sectors

The European Parliament released a strategic study on Chinese industrial overcapacity across the battery, hydrogen, semiconductor, and robotics sectors. Businesses should prepare for increased trade-defense actions and a more protectionist EU industrial policy aimed at securing domestic green-tech supply chains.

2 Apr 2026, 17:46europarl.europa.euEuropean Union

Commission Approves €500 Million Luxembourg Cleantech Manufacturing State Aid Scheme

The European Commission approved a €500 million Luxembourgish State aid scheme in March 2026 to expand domestic clean technology manufacturing capacity. This measure provides significant capital opportunities for firms scaling green industrial operations and reinforces the EU's strategic push for localized cleantech supply chains.

29 Mar 2026, 06:09ec.europa.euEuropean UnionLuxembourg

EU Commission Answer Clarifies Chips Act 2 Scope for Printed Circuit Boards and Refers to Cybersecurity Act 2

The European Commission confirmed PCBs are in scope for the upcoming "Chips Act 2" proposal and highlighted new ICT supply chain security mandates under the proposed "Cybersecurity Act 2." Electronics manufacturers should anticipate expanded investment incentives alongside stricter vetting requirements for components and services sourced from high-risk third-country suppliers.

26 Mar 2026, 19:23europarl.europa.euEuropean Union

EU Proposes Council Decision on Signing and Provisional Application of EU–Japan Agreement for Participation in Union Programmes (Horizon Europe Pillar II)

The EU has proposed a formal agreement to associate Japan with Horizon Europe Pillar II, enabling Japanese entities to participate in collaborative research calls starting retroactively from January 2026. This partnership strengthens R&D ties in strategic industrial and sustainability sectors, offering expanded opportunities for cross-border innovation and joint funding in global challenge areas.

24 Mar 2026, 11:41eur-lex.europa.euEuropean UnionJapan

European Commission Lists Biotech Act II as Planned Initiative

The European Commission has formally signaled the development of the "Biotech Act II," positioning it as a key pillar of the 2026 regulatory agenda for the Single Market. This initiative marks a strategic shift toward harmonizing the EU bioeconomy, requiring firms to prepare for new frameworks governing market access and industrial competitiveness.

22 Mar 2026, 13:29ec.europa.euEuropean Union

EU Parliament ENVI/SANT Committees To Consider Biotechnology Act Proposal On GMMs And Organ Processing

EU Parliament committees will review proposals to modernize biotechnology rules for genetically modified micro-organisms (GMMs) and human organ processing on March 24, 2026. The shift toward simplified authorizations and unlimited market consent for GMMs signals a more streamlined regulatory environment for biotech innovation and market access.

19 Mar 2026, 12:42europarl.europa.euEuropean Union

EU Commission Grants Open EU Foundry Status to 'Project Vulcan' Under Chips Act

The European Commission has officially designated 'Project Vulcan' as an open EU foundry, marking a key implementation milestone of the EU Chips Act. This designation signals the expansion of domestic semiconductor manufacturing capacity and provides the project with streamlined permitting and strategic priority within the EU supply chain ecosystem.

14 Mar 2026, 08:01ec.europa.euEuropean Union

EU Parliament Public Health Committee Draft Agenda: Votes on EU Pharmaceutical Package and European Biotech Act (18–19 March 2026)

The European Parliament's SANT Committee is scheduled to vote on the EU Pharmaceutical Package and review the European Biotech Act on March 18–19, 2026. This marks a critical step toward finalizing a comprehensive regulatory overhaul that will reshape market authorization, supply chain resilience, and safety standards for the life sciences sector.

13 Mar 2026, 10:50europarl.europa.euEuropean Union

EU Parliament SANT–ITRE Committees Schedule European Biotech Act Presentation For 19 March 2026

EU Parliament committees will review the proposed European Biotech Act on March 19, 2026, marking a key step in streamlining biotech and biomanufacturing regulations. This initiative signals a shift toward faster market access and simplified regulatory pathways for health, food, and veterinary biotech sectors to boost EU industrial competitiveness.

13 Mar 2026, 08:37europarl.europa.euEuropean Union

EU Parliament SANT Committee To Review Negotiations on Critical Medicinal Products Proposal

The European Parliament is advancing negotiations on a new framework to secure the supply and availability of critical medicinal products. This signals increasing legislative momentum toward mandatory supply chain resilience and shortage mitigation requirements for pharmaceutical operators.

13 Mar 2026, 08:37europarl.europa.euEuropean Union

EU Council Prepares Trilogues on Critical Medicines Act Proposal

The EU has entered final negotiations on the Critical Medicines Act, moving toward a finalized framework for pharmaceutical supply security. Manufacturers should prepare for new non-price procurement criteria and potential obligations for strategic stockpiling and EU-based production capacity.

11 Mar 2026, 17:27eur-lex.europa.euEuropean Union

Denmark Launches DKK 100 Million Fund For Biosolutions Facilities

Denmark has launched a DKK 100 million funding pool to support the development of biosolutions infrastructure, including microalgae-based production and microbial fermentation facilities. This initiative, coupled with Danish advocacy for streamlined EU regulations, signals a strategic push to accelerate market entry for novel bio-based products and industrial biotechnology.

6 Mar 2026, 11:17em.dkDenmarkEuropean Union

European Commission Proposes EU Science Diplomacy Framework And Publishes Research Security Monitor 2025

The European Commission launched a science diplomacy framework and research security package in February 2026 to align international R&I cooperation with EU strategic interests. Organizations should prepare for increased scrutiny of international research partnerships and technology transfers as the EU formalizes its approach to managing dual-use risks and geopolitical security.

5 Mar 2026, 09:17research-and-innovation.ec.europa.euEuropean Union

EU Parliament Research Service Analyses Quantum Technologies for Decarbonisation Ahead of Forthcoming Quantum Act

The EU is preparing a 'Quantum Act' for Q2 2026, aiming to leverage quantum computing and sensing to accelerate material discovery and decarbonization. This signals a strategic shift toward integrating quantum R&D into industrial policy, creating new opportunities for high-tech material and energy sectors.

25 Feb 2026, 19:36europarl.europa.euEuropean Union

European Parliament REGI Committee Issues Draft Opinion on European Competitiveness Fund Proposal

The European Parliament's REGI Committee has issued a draft opinion on the proposed European Competitiveness Fund (ECF), emphasizing regional cohesion and decarbonization support for the 2028–2034 period. This fund will serve as a critical vehicle for industrial subsidies and "just transition" investment, prioritizing regional innovation ecosystems and the shift toward renewable energy.

25 Feb 2026, 19:30europarl.europa.euEuropean Union

EU Council Amends Assessment of Lithuania's Recovery and Resilience Plan Under RRF Regulation

The EU Council has approved an amended Recovery and Resilience Plan for Lithuania, reallocating funds across 69 measures to address supply chain constraints and technical implementation challenges. This update prioritizes high-impact green and digital investments, specifically in renewable energy and zero-emission transport, signaling a shift toward more pragmatic and achievable sustainability targets.

12 Feb 2026, 18:35data.consilium.europa.euEuropean UnionLithuania

EU Council Schedules Working Party Meeting on European Biotech Act and GMM Directive Proposal

The EU Council is advancing negotiations on the European Biotech Act and updated rules for genetically modified micro-organisms (GMMs) in early 2026. This signals a shift toward a more integrated regulatory framework for biomanufacturing, requiring firms to align long-term R&D and market entry strategies with new EU-wide standards.

9 Feb 2026, 19:07data.consilium.europa.euEuropean Union

EU Council Consolidates European Biotech Act Amendments to Key Health Regulations

The EU Council has consolidated proposed amendments to key health and biotech regulations under the framework of the European Biotech Act. This development signals a more integrated regulatory environment for biomanufacturing and clinical trials, requiring life sciences and food tech firms to monitor evolving compliance pathways.

30 Jan 2026, 18:53data.consilium.europa.euEuropean Union

EU Proposal To Amend GMO And Human Organ Directives For Placing Genetically Modified Micro‑Organisms On The Market

The EU has proposed a Directive to modernize the regulatory framework for placing genetically modified micro-organisms (GMMs) on the market. Businesses should prepare for updated risk assessment and authorization requirements as the EU seeks to streamline biotech commercialization and medical applications.

24 Jan 2026, 09:08members.wto.orgEuropean Union

EU Committee of the Regions Adopts Opinion on Critical Medicines Act Proposal

The European Committee of the Regions has adopted its opinion on the proposed Critical Medicines Act, calling for enhanced EU manufacturing and supply security. This signals a shift toward stricter supply chain transparency and potential reshoring incentives that will impact pharmaceutical investment and operational planning.

14 Jan 2026, 11:17data.consilium.europa.euEuropean Union